By Colin Kellaher
Shares of Prime Medicine Inc. edged little successful their trading debut Thursday aft the biotechnology company's upsized archetypal nationalist offering was priced astatine the mediate of expectations.
The Cambridge, Mass., institution sold astir 10.3 cardinal shares astatine $17 apiece, compared with anterior plans to connection 8.9 cardinal shares astatine betwixt $16 and $18 each.
Prime shares were precocious changing hands astatine $16.92, down 0.5%, aft opening astatine $18.97.
Write to Colin Kellaher astatine colin.kellaher@wsj.com
English (US)